Cytoprotective effects of a cyclic rgd peptide in steatotic liver cold ischemia and reperfusion injury

Keyphrases

• Active caspase-3 20%
• Apoptotic Cells 20%
• Cold Ischemia 20%
• Cold Ischemia Injury 100%
• Cyclic RGD Peptide 40%
• Damaged Liver 20%
• Donor Liver 20%
• Donor Populations 20%
• Endothelial Cells 20%
• Fibronectin 40%
• Gelatinase 20%
• Hepatic Ischemia-reperfusion Injury 20%
• Hepatic Response 20%
• High Affinity 40%
• Inducible Nitric Oxide Synthase 20%
• Inflammatory Mediators 20%
• Integrin 40%
• Integrin Receptor 20%
• Interferon-α (IFN-α) 20%
• Ischemia-reperfusion Injury 100%
• Leukocyte Migration 20%
• Liver Ischemia-reperfusion Injury 20%
• Matrix metalloproteinase-9 (MMP-9) 20%
• MMP-9 Expression 20%
• Monocyte-derived Macrophages 20%
• Neutrophils 20%
• Orthotopic Liver Transplantation 20%
• Peptide Drugs 40%
• Putative Drug Targets 20%
• Rat Model 20%
• Recipient Survival 20%
• Response to Injury 20%
• RGD Peptide 100%
• Steatotic 60%
• Steatotic Liver 100%
• Transplantation 40%

Pharmacology, Toxicology and Pharmaceutical Science

• Arginylglycylaspartic Acid 100%
• Caspase 3 25%
• Cytoprotective Agent 100%
• Fibronectin 50%
• Gelatinase 25%
• Gelatinase B 25%
• Inducible Nitric Oxide Synthase 25%
• Integrin 50%
• Integrin Receptor 25%
• Interferon 25%
• Ischemia 100%
• Liver Ischemia 50%
• Metalloproteinase 25%
• Rat Model 25%
• Reperfusion Injury 100%
• Survival Rate 25%

Immunology and Microbiology

• Caspase 20%
• Cold Ischemia 100%
• Fibronectin 40%
• Integrin 60%
• Interferon 20%
• Leukocyte Migration 20%
• Liver Transplantation 20%
• Macrophage 20%
• Mediator 20%
• Neutrophil 20%
• Nitric Oxide Synthase 20%
• Peptides 100%
• Rat Model 20%
• Reperfusion 100%
• Survival Rate 20%